administration of 2-br- alpha-ergocryptine ( bromocriptine = cb-154 ) in combination with an estrogen-receptor blocking agent tamoxifen were performed in two patients with prolactinoma and non-functioning adenoma , respectively .
C0033375
prolactinoma
C0001430
adenoma